Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis

We conducted a registry‐based study to determine prognostic indicators of 8‐year mortality and morbidity in young children with cystic fibrosis (CF). Patients ages 1–5 years from the 1990 U.S. Cystic Fibrosis Foundation (CFF) National Patient Registry served as the study cohort (N = 3,323). Registry data provided information on baseline characteristics in 1990, 8‐year mortality, and clinical outcomes in 1998.